Eflornithine News and Research

RSS
Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

DNDi announces successful completion of SCYX-7158 Phase I study for treatment of sleeping sickness

DNDi announces successful completion of SCYX-7158 Phase I study for treatment of sleeping sickness

DNDi unveils plans to better respond to the needs of neglected patients

DNDi unveils plans to better respond to the needs of neglected patients

Virginia Tech biochemists identify potential drug target against sleeping sickness

Virginia Tech biochemists identify potential drug target against sleeping sickness

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

DNDi awarded USAID grant to develop new treatments for river blindness, elephantiasis

Bayer, DNDi sign first agreement to develop new oral treatment for onchocerciasis

Bayer, DNDi sign first agreement to develop new oral treatment for onchocerciasis

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

Celgene Global Health, DNDi expand partnership to identify new drug candidates for NTDs

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

DFID awards 5-year grant to DNDi to advance research and development for neglected diseases

WHO includes new paediatric therapeutic options to EMLc

WHO includes new paediatric therapeutic options to EMLc

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Sustained engagement, partnership needed to implement new treatments for neglected diseases

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

DNDi receives 2013 BBVA Foundation Frontiers of Knowledge and Culture Award

DNDi receives 2013 BBVA Foundation Frontiers of Knowledge and Culture Award

DNDi in Latin America wins Carlos Slim Health Award for innovations in drug development

DNDi in Latin America wins Carlos Slim Health Award for innovations in drug development

Fatal imbalance between global disease burden and drug development

Fatal imbalance between global disease burden and drug development

Fexinidazole enters Phase II/III clinical study to treat sleeping sickness

Fexinidazole enters Phase II/III clinical study to treat sleeping sickness

Malaria Box helps identify three chemical series that target treatment of NTDs

Malaria Box helps identify three chemical series that target treatment of NTDs

FIOCRUZ, DNDi and Brazil collaborate on R&D for neglected diseases

FIOCRUZ, DNDi and Brazil collaborate on R&D for neglected diseases

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

DNDi, Astellas partner on new drug discovery research for treatment of NTDs

DNDi, Astellas partner on new drug discovery research for treatment of NTDs